Status:
UNKNOWN
The Role of Transanal Tube Drainage as A Mean of Prevention of Anastomotic Leakage Anastomotic Leakage
Lead Sponsor:
University of Rome Tor Vergata
Conditions:
Rectal Cancer
Rectal Neoplasms
Eligibility:
All Genders
Phase:
NA
Brief Summary
Anastomotic leakage (AL) is considered the commonest major complication after surgery for rectal cancer. Transanal tube drainage role in the prevention of AL is still debatable.
Detailed Description
Patients who underwent low or ultralow anterior resection for rectal cancer were enrolled between 01/2015 and 06/2017. A de-Pezzer catheter was placed transanally after the creation of the anastomosis...
Eligibility Criteria
Inclusion
- Low or ultralow anterior resection with primary anastomosis for biopsy-proven primary rectal cancer
Exclusion
- No anastomosis
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03325361
Start Date
October 1 2017
End Date
June 1 2018
Last Update
October 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico Tor Vergata Hospital
Rome, RM, Italy, 00133